These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 38664263)

  • 1. Engineered platforms for mimicking cardiac development and drug screening.
    Stiefbold M; Zhang H; Wan LQ
    Cell Mol Life Sci; 2024 Apr; 81(1):197. PubMed ID: 38664263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fitting tissue chips and microphysiological systems into the grand scheme of medicine, biology, pharmacology, and toxicology.
    Watson DE; Hunziker R; Wikswo JP
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1559-1572. PubMed ID: 29065799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered models of the human heart: Directions and challenges.
    Stein JM; Mummery CL; Bellin M
    Stem Cell Reports; 2021 Sep; 16(9):2049-2057. PubMed ID: 33338434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-dimensional cardiac models: a pre-clinical testing platform.
    Groen E; Mummery CL; Yiangou L; Davis RP
    Biochem Soc Trans; 2024 Jun; 52(3):1045-1059. PubMed ID: 38778769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-assembling human heart organoids for the modeling of cardiac development and congenital heart disease.
    Lewis-Israeli YR; Wasserman AH; Gabalski MA; Volmert BD; Ming Y; Ball KA; Yang W; Zou J; Ni G; Pajares N; Chatzistavrou X; Li W; Zhou C; Aguirre A
    Nat Commun; 2021 Aug; 12(1):5142. PubMed ID: 34446706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering Cardiac Tissue for Advanced Heart-On-A-Chip Platforms.
    Chen X; Liu S; Han M; Long M; Li T; Hu L; Wang L; Huang W; Wu Y
    Adv Healthc Mater; 2024 Jan; 13(1):e2301338. PubMed ID: 37471526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From cardiac tissue engineering to heart-on-a-chip: beating challenges.
    Zhang YS; Aleman J; Arneri A; Bersini S; Piraino F; Shin SR; Dokmeci MR; Khademhosseini A
    Biomed Mater; 2015 Jun; 10(3):034006. PubMed ID: 26065674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart-on-a-chip platforms and biosensor integration for disease modeling and phenotypic drug screening.
    Criscione J; Rezaei Z; Hernandez Cantu CM; Murphy S; Shin SR; Kim DH
    Biosens Bioelectron; 2023 Jan; 220():114840. PubMed ID: 36402101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human iPSC-Based Modeling of Central Nerve System Disorders for Drug Discovery.
    Qian L; Tcw J
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33530458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heart-on-Chip for Combined Cellular Dynamics Measurements and Computational Modeling Towards Clinical Applications.
    Park J; Wu Z; Steiner PR; Zhu B; Zhang JXJ
    Ann Biomed Eng; 2022 Feb; 50(2):111-137. PubMed ID: 35039976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toward improved myocardial maturity in an organ-on-chip platform with immature cardiac myocytes.
    Sheehy SP; Grosberg A; Qin P; Behm DJ; Ferrier JP; Eagleson MA; Nesmith AP; Krull D; Falls JG; Campbell PH; McCain ML; Willette RN; Hu E; Parker KK
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1643-1656. PubMed ID: 28343439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development.
    Davis RP; van den Berg CW; Casini S; Braam SR; Mummery CL
    Trends Mol Med; 2011 Sep; 17(9):475-84. PubMed ID: 21703926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Organ-On-A-Chip Platforms: A Convergence of Advanced Materials, Cells, and Microscale Technologies.
    Ahadian S; Civitarese R; Bannerman D; Mohammadi MH; Lu R; Wang E; Davenport-Huyer L; Lai B; Zhang B; Zhao Y; Mandla S; Korolj A; Radisic M
    Adv Healthc Mater; 2018 Jan; 7(2):. PubMed ID: 29034591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid-on-a-chip and body-on-a-chip systems for drug screening and disease modeling.
    Skardal A; Shupe T; Atala A
    Drug Discov Today; 2016 Sep; 21(9):1399-1411. PubMed ID: 27422270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional in vitro tissue culture models of brain organoids.
    Gong J; Meng T; Yang J; Hu N; Zhao H; Tian T
    Exp Neurol; 2021 May; 339():113619. PubMed ID: 33497645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional screening in human cardiac organoids reveals a metabolic mechanism for cardiomyocyte cell cycle arrest.
    Mills RJ; Titmarsh DM; Koenig X; Parker BL; Ryall JG; Quaife-Ryan GA; Voges HK; Hodson MP; Ferguson C; Drowley L; Plowright AT; Needham EJ; Wang QD; Gregorevic P; Xin M; Thomas WG; Parton RG; Nielsen LK; Launikonis BS; James DE; Elliott DA; Porrello ER; Hudson JE
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):E8372-E8381. PubMed ID: 28916735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives of future lung toxicology studies using human pluripotent stem cells.
    Masui A; Hirai T; Gotoh S
    Arch Toxicol; 2022 Feb; 96(2):389-402. PubMed ID: 34973109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3D Engineering of Ocular Tissues for Disease Modeling and Drug Testing.
    Boutin ME; Hampton C; Quinn R; Ferrer M; Song MJ
    Adv Exp Med Biol; 2019; 1186():171-193. PubMed ID: 31654390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biofabrication strategies for cardiac tissue engineering.
    Okhovatian S; Khosravi R; Wang EY; Zhao Y; Radisic M
    Curr Opin Biotechnol; 2024 Aug; 88():103166. PubMed ID: 38941865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.